Header Logo

Vu Hoang Tran

Concepts (121)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
5
2018
253
1.910
 Why?
Myocardial Infarction
5
2022
915
1.360
 Why?
Anxiety Disorders
2
2018
197
1.010
 Why?
Tachycardia, Ventricular
2
2018
131
1.000
 Why?
Patient Discharge
2
2018
507
0.860
 Why?
ST Elevation Myocardial Infarction
3
2022
96
0.810
 Why?
Non-ST Elevated Myocardial Infarction
2
2018
33
0.710
 Why?
Circulating Tumor DNA
4
2025
10
0.680
 Why?
Nutrition Surveys
2
2017
144
0.620
 Why?
Percutaneous Coronary Intervention
1
2022
222
0.580
 Why?
Early Detection of Cancer
4
2025
321
0.560
 Why?
Hyperglycemia
1
2018
105
0.550
 Why?
Ventricular Fibrillation
1
2018
107
0.540
 Why?
Deficiency Diseases
1
2017
13
0.530
 Why?
Iodine
1
2017
20
0.530
 Why?
Arrhythmias, Cardiac
1
2018
158
0.530
 Why?
Patient Admission
1
2018
198
0.510
 Why?
Cardiovascular Agents
1
2017
104
0.490
 Why?
Drug Utilization
1
2017
208
0.480
 Why?
Depressive Disorder
1
2018
286
0.480
 Why?
Hospital Mortality
2
2022
870
0.450
 Why?
Length of Stay
1
2017
819
0.420
 Why?
Aged
13
2025
14662
0.410
 Why?
Coronary Artery Disease
1
2017
320
0.400
 Why?
Middle Aged
12
2025
17921
0.400
 Why?
Healthcare Disparities
1
2017
374
0.390
 Why?
Risk Factors
7
2018
5341
0.380
 Why?
Female
16
2025
33380
0.360
 Why?
Male
14
2025
30321
0.360
 Why?
Incidence
4
2018
1385
0.350
 Why?
Biomarkers, Tumor
5
2025
512
0.340
 Why?
Prognosis
4
2018
1769
0.330
 Why?
Massachusetts
5
2018
2096
0.330
 Why?
Atrial Fibrillation
2
2018
854
0.330
 Why?
Humans
23
2025
64278
0.290
 Why?
Cell-Free Nucleic Acids
2
2025
14
0.280
 Why?
Prospective Studies
5
2025
3318
0.250
 Why?
Time Factors
3
2018
3725
0.250
 Why?
DNA Methylation
2
2025
294
0.240
 Why?
Neoplasms
3
2025
1392
0.230
 Why?
Logistic Models
2
2018
1270
0.220
 Why?
Aged, 80 and over
3
2018
5528
0.210
 Why?
Patient Readmission
2
2018
432
0.210
 Why?
Pseudomonas Infections
1
2023
54
0.200
 Why?
Liver Neoplasms
2
2023
306
0.200
 Why?
Prevalence
2
2017
1407
0.200
 Why?
Biomarkers
2
2018
1431
0.190
 Why?
Exome
1
2021
77
0.170
 Why?
Carcinoma, Hepatocellular
1
2023
181
0.170
 Why?
Risk Assessment
2
2018
2048
0.170
 Why?
Pneumonia
1
2023
291
0.170
 Why?
Gene Frequency
1
2020
123
0.160
 Why?
Coronary Artery Bypass
1
2022
297
0.160
 Why?
United States
3
2018
7923
0.160
 Why?
Cardiovascular Diseases
2
2018
848
0.160
 Why?
Cardiac Catheterization
1
2022
292
0.160
 Why?
Genetic Testing
1
2020
140
0.150
 Why?
Alleles
1
2020
448
0.150
 Why?
Mutation
2
2025
2629
0.150
 Why?
Theranostic Nanomedicine
1
2018
8
0.150
 Why?
Radiation-Sensitizing Agents
1
2018
15
0.150
 Why?
Odds Ratio
2
2018
759
0.140
 Why?
Genotype
1
2020
668
0.140
 Why?
Leukocyte Count
1
2018
99
0.140
 Why?
Vietnam
3
2025
175
0.140
 Why?
Gadolinium
1
2018
110
0.140
 Why?
Hospitalization
2
2022
1368
0.130
 Why?
Mortality
1
2018
161
0.130
 Why?
Protective Factors
1
2017
33
0.130
 Why?
Herpes Zoster
1
2017
24
0.130
 Why?
Cerebrovascular Disorders
1
2017
81
0.130
 Why?
Breast Neoplasms
1
2025
1213
0.120
 Why?
Chi-Square Distribution
1
2017
412
0.120
 Why?
Linear Models
1
2017
408
0.120
 Why?
Cohort Studies
2
2021
2605
0.120
 Why?
Blood Glucose
1
2018
487
0.120
 Why?
Survival Rate
1
2018
859
0.120
 Why?
Drug Monitoring
1
2017
206
0.120
 Why?
Medication Adherence
1
2017
205
0.120
 Why?
Follow-Up Studies
2
2018
2482
0.120
 Why?
Multivariate Analysis
1
2017
930
0.110
 Why?
Disease Progression
1
2018
1176
0.110
 Why?
Stroke
3
2018
1196
0.100
 Why?
Anticoagulants
1
2018
511
0.100
 Why?
Adult
5
2025
17133
0.100
 Why?
Registries
1
2017
885
0.100
 Why?
Health Services Accessibility
1
2018
575
0.100
 Why?
Nanoparticles
1
2018
523
0.090
 Why?
Depression
1
2018
909
0.090
 Why?
Quality of Life
1
2018
1257
0.080
 Why?
Treatment Outcome
2
2018
5696
0.080
 Why?
Retrospective Studies
2
2025
6740
0.080
 Why?
Cross-Sectional Studies
1
2017
2621
0.080
 Why?
Tobramycin
1
2023
7
0.050
 Why?
DNA, Neoplasm
1
2023
59
0.050
 Why?
Rabbits
1
2023
333
0.050
 Why?
Pseudomonas aeruginosa
1
2023
108
0.050
 Why?
Microbial Sensitivity Tests
1
2023
209
0.050
 Why?
Shock, Cardiogenic
1
2022
104
0.040
 Why?
Hospitals
1
2022
390
0.040
 Why?
Genome-Wide Association Study
1
2020
361
0.040
 Why?
Publication Bias
1
2018
21
0.040
 Why?
Georgia
1
2018
88
0.040
 Why?
Sex Distribution
1
2018
251
0.030
 Why?
Age Distribution
1
2018
258
0.030
 Why?
Polymorphism, Single Nucleotide
1
2020
497
0.030
 Why?
Herpes Zoster Ophthalmicus
1
2017
6
0.030
 Why?
Forecasting
1
2018
233
0.030
 Why?
Anti-Bacterial Agents
1
2023
800
0.030
 Why?
Head and Neck Neoplasms
1
2018
167
0.030
 Why?
Administration, Oral
1
2018
374
0.030
 Why?
Phenotype
1
2020
1222
0.030
 Why?
Venous Thromboembolism
1
2018
147
0.030
 Why?
Brain Neoplasms
1
2018
313
0.030
 Why?
Comorbidity
1
2018
1119
0.030
 Why?
Melanoma
1
2018
331
0.030
 Why?
Randomized Controlled Trials as Topic
1
2018
788
0.030
 Why?
Pregnancy
1
2020
2370
0.020
 Why?
Animals
2
2023
20963
0.020
 Why?
Surveys and Questionnaires
1
2018
2738
0.020
 Why?
Mice
1
2018
11004
0.010
 Why?
Tran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (121)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_